**taken from PGE input
Royal Philips is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovations leverage advanced technology and deep clinical and consumer insights to deliver professional health solutions for healthcare providers and their patients in the hospital and personal health solutions for consumers at home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health.
PHILIPS MEDICAL SYSTEMS NEDERLAND BV (PMS)
TEXT INPUT MISSING
PMS contribution to PreciseOnco
TEXT INPUT MISSING
MATTHIAS SIMONS
Matthias Simon is a physicist by training and holds a PhD in experimental physics. He joined Philips in 1998 as a Research Scientist in Aachen, Germany, where he worked on several projects focusing on X-ray conversion materials, X-ray detectors, and imaging physics.
In 2011, he transferred to Philips Research in Eindhoven as a Senior Scientist, where he investigated, in collaboration with several external research institutes, the use of thin-film organic electronics for X-ray detection. While further expanding his expertise in diagnostic and interventional X-ray and CT systems and applications, Matthias also led projects on dual-energy and spectral X-ray concepts.
From 2018 to 2021, he worked on a European public–private partnership project focused on stroke imaging using dual-energy cone-beam CT.
In 2024, he joined the Philips IGT Systems Front-End Innovation department in Best, where he is currently involved in advanced development projects aimed at improving CBCT imaging in the neuro and oncology domains.
NISHANT SINGH
Nishant Singh is an R&D Engineer in the X-ray Components department within the Image Chain cluster of the Image Guided Therapy (IGT) Systems group at Philips Medical Systems in Best, the Netherlands. He holds a Master’s degree in Electrical Engineering with a specialization in signal processing and communication systems, and has spent the past eleven years contributing to the development of advanced medical imaging technologies at Philips, spanning diagnostic X-ray to image-guided therapy systems.
His work and interests focus on algorithm development for X-ray cone-beam imaging, particularly in the areas of scatter mitigation and reconstruction quality improvement. He has extensive experience with anti-scatter grids, software-based scatter correction methods, and mathematical modeling for image quality enhancement. His approach combines strong theoretical foundations with hands-on validation, frequently testing and refining concepts in the laboratory to ensure robust and clinically relevant performance.
As part of the PreciseOnco IHI project, he contributes to Work Package 2, which focuses on the evaluation and optimization of dual-layer X-ray detectors and next-generation anti-scatter grid technologies. The goal of his work is to advance dual-layer detector-based spectral cone-beam imaging performance for abdominal applications through improved hardware–software integration and physics-driven algorithmic innovation.
JULISCA CESAR
Julisca Cesar is a Senior Clinical Scientist specializing in Interventional Oncology within the Image Guided Therapy Systems division at Philips. In this role, she bridges scientific theory and clinical practice to support the development of innovative, minimally invasive cancer treatments.
Her work involves close collaboration with medical professionals and engineers to enhance imaging technologies as well as planning and navigation software solutions, with the goal of improving patient outcomes. Julisca holds a Research Master’s degree in Epidemiology from Rijksuniversiteit Groningen, where she developed a strong foundation in medical research and healthcare innovation.
Her professional journey includes an internship at the World Health Organization (WHO), during which she contributed to public health initiatives. She began her career at Philips as an Associate Healthcare Consultant and later transitioned into roles focused on clinical marketing and scientific research within image-guided therapy.
Actively engaged in the medical community, Julisca participates in educational symposia and collaborative projects aimed at advancing interventional oncology. She is passionate about driving innovation in image-guided therapies and translating research into clinically impactful solutions that enhance patient care.
PEDRO RODRIGUES
Pedro Rodrigues is a Clinical Scientist in Oncology at Philips, where he owns the clinical roadmap for IntelliSpace Portal (AVW) Advanced Visualization Solutions in Oncology and General Radiology. With more than 15 years of experience in diagnostic imaging and image-guided therapies, he works at the intersection of clinical needs, artificial intelligence, and product strategy.
His work focuses on translating emerging technologies, particularly artificial intelligence and deep learning, into validated, regulatory-compliant clinical solutions. He drives co-creation initiatives with academic and clinical partners, defines evidence-generation strategies supporting FDA 510(k) and EU MDR submissions, and contributes to shaping innovation funnels.
His background spans nuclear medicine (PET/CT), MR-HIFU, radiotherapy, and integrated diagnostics for immuno-oncology. Pedro combines deep technical expertise in system validation, high-performance computing, and imaging workflows with strong regulatory and market-shaping experience.
His career bridges academic research and industrial R&D, enabling him to connect customer insights, technological feasibility, and clinical impact into scalable healthcare solutions.
OLIVER TOURIGNAN
Olivier Tousignant is a Technologist in X-ray Detectors at Philips ICC X-ray Components. He brings more than 25 years of experience specializing in X-ray detector system design, innovation, and the introduction of new products. Over the course of his career, he has developed deep expertise across a wide range of X-ray detection technologies.
His areas of knowledge include photon-counting CT (PCCT), CT, CBCT, radiography, mammography, nuclear medicine, dental applications, non-destructive testing (NDT), and spectral imaging. This broad technical foundation is primarily focused on performance characterization, reliability, and verification and validation activities.
Throughout his career, Olivier has held diverse roles at key companies in the field and has participated in numerous product designs that achieved commercial success. His involvement has contributed significantly to the advancement, performance, and market relevance of X-ray detector products.
PHILIPS FRANCE (PFC)
Philips France is the French entity of Koninklijke Philips N.V., a global leader in health technology focused on improving health and well being through meaningful innovation. The organization operates primarily from its headquarters at 33 rue de Verdun, 92150 Suresnes, with additional sites in Paris and in regions.
Philips France’s core activities align with Philips’ global strategic domains – Diagnosis & Treatment, Connected Care, and Personal Health – providing advanced medical imaging, patient monitoring, health informatics, and consumer health solutions for both healthcare professionals and the general public.
Historically recognized for its contributions to radiology and medical imaging, the French organization plays an active role in deploying high technology solutions across hospitals and clinics, leveraging Philips’ long standing global expertise, which includes leadership in MedTech patent filings and a sustained commitment to R&D investment (approximately 9% of global revenue in 2024).
As part of the broader Philips group, Philips France contributes to the company’s mission to improve 2.5 billion lives per year by 2030, including underserved populations, by enabling better diagnostic accuracy, more efficient care pathways, and innovations in preventive and home based care. Its activities span both commercial operations and certified training, with Philips France registered as a Qualiopi certified training organization in the health domain.
The company is structured as a SASU (société par actions simplifiée unipersonnelle) with a capital of €3.1 million and operates within the French legal and industrial framework of the Métallurgie collective agreement (IDCC 3248). Its declared main activity includes the development, manufacturing, and commercialization of electrical and electronic equipment, particularly within the healthcare sector. Employment figures for Philips France range between 500 and 999 employees, reflecting its significant national footprint and engagement in both healthcare technology and commercial support operations.
Philips France also maintains a strong presence in the country’s healthcare innovation ecosystem through ongoing partnerships with medical institutions, R&D initiatives, and participation in national and regional healthcare projects. Its Paris site contribute specialized capabilities in AI driven diagnostics and cloud based health technologies, reinforcing Philips’ strategic focus on data enabled, intelligent care solutions.
Overall, Philips France combines global technological leadership with local expertise to support the transformation of healthcare delivery in France, focusing on sustainable impact, innovation, and high quality care experiences across the health continuum.
PFC contribution to PreciseOnco
Philips France will support the French clinical partners, HCL and APHP, in running the clinical studies, bringing technical knowledge on the imaging systems, providing advanced training for the clinical staff, contributing to protocol optimization, data collection and analysis, and publications.
Employees from Philips France will also lead or contribute to different work packages: WP1 for data management; WP2 for data collection for algorithm development and evaluation with the clinical partners; WP3 for optimizing workflow and image acquisition protocols for interventional oncology procedures; WP4 for developing and validating specific biomarkers based on spectral imaging for treatment endpoint determination and follow-up.
PHILIPPE COULON
Philippe Coulon is Director of CT Clinical Science Radiology at the Philips CT Business Unit. He holds an engineering degree in physics and chemistry as well as a PhD in physics.
With more than 20 years of experience in CT technologies and applications, Philippe has built deep expertise across a broad range of domains, including spectral CT and interventional CT. His work focuses on advancing clinical science and supporting innovation in CT imaging to address evolving clinical needs.
NINA BUFI
Nina Bufi is an Innovation Partnership Lead at Philips, where she structures, steers, and scales enterprise-level innovation partnerships across multiple business units and clinical domains. She owns partnership strategy, governance, and execution, acting as the central orchestrator between internal teams and external partners to translate shared ambitions into concrete and measurable innovation outcomes.
An engineer with a PhD and more than 10 years of experience in healthcare innovation, Nina has held roles across startups, large corporates, and government entities, giving her a strong track record in managing complex interfaces and multi-stakeholder ecosystems. She is recognized for her ability to align diverse perspectives, build trusted relationships, and drive high-impact, first-of-a-kind innovation initiatives from strategy to execution.
JEAN-MICHEL ROUET
Jean-Michel Rouet is a Senior Data Scientist at Philips France, where he has been conducting research since 2000 on medical image post-processing algorithms. He holds an engineering degree and a PhD in medical image processing.
His current work focuses on computer vision and AI-based methods for quantitative medical image analysis, with research contributions spanning cardiovascular, chest, and liver imaging in CT, MR and Ultrasound.
ALEXIA VIDAL
Alexia Vidal is a Clinical Development Scientist at Philips, where she drives strategic innovation initiatives and develops a strong and engaged Key Opinion Leader network in Image Guided Therapy across France. Trained as an engineer, she holds a PhD in neurosciences and has more than six years of experience in Healthcare Medical Affairs across startups and large organizations.
She brings strong expertise in translating research and development into clinically relevant and impactful innovations for end users.
PHILIPS GmbH (PGE)
The Philips GmbH with headquarter in Hamburg, Germany is the base for important industrial activities and German medical research. In the Hanseatic city, the company develops and produces X-ray tubes and generators, while the manufacturing and development center for medical technology also produces X-ray systems.
German medical research, Philips Innovative Technologies, with its main research areas of medical imaging systems, image formation and image analysis, is also based on the Philips Campus in Hamburg. 60 scientists from the fields of physics, mathematics, electrical engineering, and computer science are working on future challenges in global healthcare. Innovative technology concepts for computed tomography, magnetic resonance imaging, ultrasound, diagnostic and interventional X-ray and artificial intelligence in health technology are being researched in collaboration with universities and clinics.
PGE contribution to PreciseOnco
The main role of PGE in the project is in Work package 2 and more specifically in Task 2.3 Spectral CT image quality improvement and dose reduction. It is about Image formation algorithm development, testing and evaluation for image noise Reduction, spatial resolution enhancement and artifact removal for diagnostic conventional and spectral CT.
MICHAEL GRASS
Michael Grass is a Principal Scientist in the medical imaging research department at Philips Innovative Technologies, located in Hamburg, Germany. He holds a PhD in Physics and is an Associate Professor in the engineering faculty at Hamburg University of Technology, Germany.
His current research areas include image reconstruction, artificial intelligence, and machine learning, with a strong focus on tomographic image formation. Michael has extensive experience across a broad spectrum of imaging modalities, including X-ray, CT, cone-beam CT, intravascular imaging, and MRI. He also brings a proven track record in translating innovation into successful medical imaging products.
PHILIPS Belgium Commercial (PBC)
Philips Belgium Commercial is the Belgian commercial entity of Koninklijke Philips N.V., operating primarily in the healthcare and pharmaceutical wholesale sector. The company is headquartered at Burgemeester Etienne Demunterlaan 1, 1090 Jette (Brussels). It was established on 25 June 2015. Its core business activity is the wholesale distribution of pharmaceutical and medical products.
Overall, Philips Belgium Commercial plays a central role in Philips’ Benelux commercial operations, combining structured distribution, regulatory compliance, and marketplace support to deliver advanced healthcare products efficiently across Belgium. Philips Belgium Commercial is supporting hospitals, clinics, pharmacies, and medical professionals with access to high quality equipment, devices, and associated medical supplies.
PBC contribution to PreciseOnco
Alain Vlassenbroek is member of the CT/AMI Clinical Science Group, which is part of the CT Business Unit. Philips Belgium Commercial is Hosting Business Unit employees, based in Belgium.
ALAIN VLASSENBROEK
Dr. Alain Vlassenbroek is a Clinical Scientist at Philips. He holds a Master’s degree in Science (Physics) as well as a PhD in Physics in the field of Nuclear Magnetic Resonance from Université Libre de Bruxelles (ULB). He has 31 years of experience in CT technologies and applications, including spectral CT, contributing to the advancement of clinical science and innovation in computed tomography.